Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.

Becton, Dickinson and Company (BD) has announced its submission of an application to the FDA for an at-home human papillomavirus (HPV) test.

Trividia Health UK has launched the TRUEplus 5-Bevel Pen Needles in the country, marking the product's first entry outside the US.

Founder Juan José Chacón-Quiros discusses how Establishment Labs is transforming breast reconstruction and aesthetics with innovative, patient-focused solutions.

AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.

Axonius has acquired New York-headquartered healthcare cybersecurity firm Cynerio in a $100m cash and stock deal.

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.

Healthcare firm OSR Holdings (OSRH) has signed a term sheet to acquire South Korea's medical device company, Woori IO (WORIO).

GE HealthCare and Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.